Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Jan 21;17(1):e0262760. doi: 10.1371/journal.pone.0262760

Assessing fetal growth in Africa: Application of the international WHO and INTERGROWTH-21st standards in a Beninese pregnancy cohort

Emmanuel Yovo 1,*, Manfred Accrombessi 1,2, Gino Agbota 1,3, Alice Hocquette 4, William Atade 1, Olaiitan T Ladikpo 1, Murielle Mehoba 1, Auguste Degbe 1, Ghyslain Mombo-Ngoma 5,6,7,8, Achille Massougbodji 1, Nikki Jackson 9, Nadine Fievet 10, Barbara Heude 11, Jennifer Zeitlin 4, Valérie Briand 8,12,*
Editor: Clive J Petry13
PMCID: PMC8782373  PMID: 35061819

Abstract

Background

Fetal growth restriction is a major complication of pregnancy and is associated with stillbirth, infant death and child morbidity. Ultrasound monitoring of pregnancy is becoming more common in Africa for fetal growth monitoring in clinical care and research, but many countries have no national growth charts. We evaluated the new international fetal growth standards from INTERGROWTH-21st and WHO in a cohort from southern Benin.

Methods

Repeated ultrasound and clinical data were collected in women from the preconceptional RECIPAL cohort (241 women with singleton pregnancies, 964 ultrasounds). We modelled fetal biometric parameters including abdominal circumference (AC) and estimated fetal weight (EFW) and compared centiles to INTERGROWTH-21st and WHO standards, using the Bland and Altman method to assess agreement. For EFW, we used INTERGROWTH-21st standards based on their EFW formula (IG21st) as well as a recent update using Hadlock’s EFW formula (IG21hl). Proportions of fetuses with measurements under the 10th percentile were compared.

Results

Maternal malaria and anaemia prevalence was 43% and 69% respectively and 11% of women were primigravid. Overall, the centiles in the RECIPAL cohort were higher than that of INTERGROWTH-21st and closer to that of WHO. Consequently, the proportion of fetuses under 10th percentile thresholds was systematically lower when applying IG21st compared to WHO standards. At 27–31 weeks and 33–38 weeks, respectively, 7.4% and 5.6% of fetuses had EFW <10th percentile using IG21hl standards versus 10.7% and 11.6% using WHO standards.

Conclusion

Despite high anemia and malaria prevalence in the cohort, IG21st and WHO standards did not identify higher than expected proportions of fetuses under the 10th percentiles of ultrasound parameters or EFW. The proportions of fetuses under the 10th percentile threshold for IG21st charts were particularly low, raising questions about its use to identify growth-restricted fetuses in Africa.

Introduction

Fetal growth restriction (FGR), or poor growth of a fetus during pregnancy, is associated with an increased risk of infant mortality and morbidity at birth and in childhood [13]. Therefore, early detection and surveillance of growth-restricted fetuses can contribute to reducing the short- and long-term consequences of FGR [4, 5]. Because defining and identifying FGR is difficult, small-for-gestational age (SGA) is commonly used as a proxy. SGA is defined as a fetal weight or birthweight below the 10th centile for a given gestational age (GA) according to a reference chart [6, 7]. In low- and middle-income countries (LMICs), about 20% of newborns are considered to be SGA at birth and account for 25% of neonatal deaths [3]. Maternal undernutrition, gestational hypertension, and infectious diseases (e.g. malaria, HIV) are among the main causes of FGR and SGA in these countries [810].

In Africa, with limited exceptions [11], the reference charts used for fetal growth monitoring come from high-income countries (HICs), where populations have different characteristics and risk factors for FGR [8, 12]. Recently, two international fetal growth standards were developed for global use: the INTERGROWTH-21st and the World Health Organization (WHO) [13, 14] standards. Their comparison to national reference charts worldwide has yielded contradictory results [1521]. However, few studies have been carried out in African populations [22]; assessment of these charts requires accurate GA estimates by ultrasound scans (US) along with serial fetal biometric parameters, which are still uncommon in the African context.

The RECIPAL study, which established a preconceptional prospective cohort of pregnant women in Benin, offers an opportunity to contribute to the assessment of these new standards in Africa. Our objective was to compare fetal growth in the RECIPAL cohort based on models of fetal biometric measurements and estimated fetal weight (EFW) centiles with the WHO and INTERGROWTH-21st standards as well as the one existing African EFW chart from Tanzania [11]. Given the high prevalence of malaria, anemia and under-nutrition among pregnant women in Benin, we hypothesized that the proportion of fetuses classified as SGA by each international prescriptive chart would be greater than 10%, as these charts were developed in low-risk pregnant women.

Methods

Study design, population, and procedures

The RECIPAL study was conducted in Sô-Ava and Abomey-Calavi districts, south Benin, in 2014–2017. Briefly, women of reproductive age (18–45 years old) were recruited at the community level and followed monthly for a maximum period of 24 months until becoming pregnant [23]. During the monthly home visit after enrollment, the first day of last menstrual period (LMP) was recorded and a urinary pregnancy test was performed. The subsample of women who became pregnant was then followed monthly from early pregnancy to delivery. Data on risk factors for FGR such as malaria, HIV, gestational hypertension, malnutrition, anaemia, alcohol consumption, smoking, and urogenital infection were collected either at recruitment before conception or monthly during pregnancy. During pregnancy, women received intermittent preventive treatment with sulfadoxine-pyrimethamine and an insecticide-treated net, plus folic acid and iron supplementation. In case of malaria, women were treated with quinine (in the 1st trimester) or artemisinin-based combinations (in the 2nd and 3rd trimesters). Newborns were weighed within 1 hour of birth using an electronic digital scale with an accuracy of 2g (SECA 757; SECA, Germany).

The RECIPAL study received ethical approval from the Beninese Ethics Committee of the Institut des Sciences Biomédicales Appliquées and Ministry of Health. All participants gave informed written consent before enrollment in the cohort.

Ultrasound examination

The first US for dating the pregnancy was performed between 9 and 13 weeks of gestation (wg) (±1week); dating was based on the crown-rump length (CRL) measurement using the Robinson’s formula [24]. GA was based on the LMP if the difference between the LMP and CRL was less than 7 days or on CRL if the difference was >7. Then, four additional standardized USs were performed every 6 weeks (±1week) for fetal growth monitoring, so that the possible ranges of GA were 15–20, 21–26, 27–32 and 33–38wg. At each US, head circumference (HC), abdominal circumference (AC), and femur length (FL) were measured twice in two separate subsequent images. Fetal weight was estimated based on HC, FL, and AC parameters using both the Hadlock formula [25] and the INTERGROWTH-21st formula [26]. USs were performed by four skilled obstetrician-gynaecologists using a portable ultrasound system (high-resolution ultrasound system, 5–2 MHz C60 abdominal probe; Sonosite M-TURBO, Washington State, USA). Throughout the study, 10% of the images were reviewed by a senior obstetrical sonographer to verify that the measurements fulfilled the INTERGROWTH-21st guidelines [27].

Statistical analysis

For each US and each set of fetal measurements, Bland and Altman plots were used to assess the intra-operator variability. After selecting measurements that fell within acceptable ranges for each parameter [28], the mean was calculated and used for comparison with the reference values. The few sets of measurements that fell outside the acceptable ranges were mainly due to data entry errors and were corrected by returning to the source data, then included in data analysis.

Centiles for AC, HC, FL, and EFW were derived from 15 to 38 wg with the RECIPAL data using quantile regression analysis, following the WHO modelling approach [13]. In our study, RECIPAL EFW were estimated with both the Hadlock formula [25] and the INTERGROWTH-21st formula [14] (see below). The quantile regression calculates quantiles (ie percentiles) directly from the observed measurements without making assumptions about their distribution. To assess the validity of the regression model applied to the RECIPAL data, the proportion of fetuses with observed values below the threshold of each percentile (i.e., 3th, 5th, 10th, 25th, 50th, 75th, 90th, 95th, and 97th) was calculated.

The 10th, 50th, and 90th centiles for AC, HC, FL, and EFW centiles from RECIPAL cohort were compared with both INTERGROWTH-21st and WHO centiles, as well as those from a recent EFW growth chart that was developed in Tanzania [11]. Two INTERGROWTH-21st standards for EFW were used: the original ones using the INTERGROWTH-21st formula for calculating EFW (hereafter denoted IG21st) [26], and recently published standards using the Hadlock formula for calculating EFW (hereafter denoted IG21hl) [29]. This new standard follows research showing Hadlock formula to be more accurate for the prediction of fetal weight. Therefore, EFW were estimated with the Hadlock formula for comparison between RECIPAL, IG21hl, WHO and the Tanzanian standards, or with the INTERGROWTH-21st formula for comparison between RECIPAL and IG21st. The agreement was assessed using the Bland and Altman method of differences analysis of two quantitative measurements [30, 31]. For instance, the percentage difference of the 10th centile of AC compared between RECIPAL and WHO was calculated as follows: [(AC10th_WHO–AC10th_RECIPAL)/Mean AC10th] * 100 where AC10th_WHO is the value of the 10th centile for AC based on WHO standards, AC10th_RECIPAL is the value of the 10th centile for AC based on RECIPAL charts, and Mean AC10th is the mean of AC10th between WHO and RECIPAL. A negative percentage difference means that the RECIPAL centile is higher than that of WHO. Percentage differences were plotted by GA and the bias (mean percentage differences between the paired data) was calculated. The closer these differences are to zero, the more similar the paired data are to each other.

The proportion of fetuses with HC, AC, FL, and EFW less than the 10th centile of INTERGROWTH-21st and WHO standards, as well as EFW for the Tanzania standards at 27–32wg and at 33–38wg was calculated.

Stata version 13 for Windows (Stata Corp., College Station, TX) was used for all statistical analyses.

Results

The RECIPAL study included 411 pregnant women, of whom 273 (66.4%) were followed until delivery and 254 had at least one US between 27–38 wg and gave birth to a live singleton baby (Fig 1). These women were included in the calculation of the proportion of fetuses with AC, HC, FL and EFW centiles below the 10th. Fetal growth modeling was carried out on the 241 (92%) women who underwent the four scheduled growth monitoring USs.

Fig 1. Flowchart diagram of the study.

Fig 1

RECIPAL cohort, Southern Benin, 2014–2017.

The first US for dating the pregnancy was performed at a mean of 11 wg. The 241 women received the four scheduled USs within the expected GA windows, at 16, 22, 28, and 34 wg respectively (S1 Fig). Overall, 964 ultrasounds were performed for fetal growth monitoring.

Women’s demographic characteristics and main risk factors for FGR

The mean maternal age was 26.7 years; 11% of women were primigravid (Table 1).

Table 1. Characteristics of the 254 pregnant women included in the ultrasound study.

RECIPAL cohort, Southern Benin, 2014–2017.

Characteristics Category Mean (SD) or %
Age (years) 26.7 (4.9)
< 24 y 24.2%
24–30 y 55.6%
> 30 y 20.2%
Ethnic group Toffin 74.3%
Fon 7.7%
Aïzo 12.9%
Others a 5.1%
Education Illiterate 71.7%
Socioeconomic status* Low 34.1%
Mild 40.6%
High 25.3%
Gravidity 1 11.2%
2 16.2%
3 22.0%
≥4 50.6%
Pre-pregnancy BMI (kg/m²) 22.8 (4.2)
< 18.5 8.9%
18.5–25 67.2%
≥ 25 23.9%
Anaemia before conception Yes 57.2%
Height (cm) 158.3 (6.2)
Short stature (height < 155 cm) Yes 27.4%
Malaria infection before conception Yes 5.9%
Number of ANC visits during pregnancy b 8.9 (1.8)
Gestational age at the first ANC visit (weeks) c 7.1 (2.6)
Gestational hypertension ≥ 1 episode(s) 2.6%
Anaemia during pregnancy ≥ 1 episode(s) 69.5%
Malaria infection during pregnancy ≥ 1 episode(s) 43.1%
Clinical malaria infection during pregnancy d ≥ 1 episode(s) 22.1%

Abbreviations: SD, standard deviation; IQR, interquartile range; ITN, insecticide-treated bed net; BMI, body mass index; ANC visit, antenatal care visit.

* Socioeconomic status was approximated using a synthetic score combining occupation and ownerships of assets, which was then categorized according to the tertiles in the whole RECIPAL cohort.

a Other ethnic groups: Yoruba, Adja, Goun, Ahoussa, Cotafon, Mahi, Sahoue.

b Including both scheduled and unscheduled visits.

c Gestational age was estimated using ultrasound scan or last menstrual period.

d Positive thick blood smear or positive rapid diagnostic test with an axillary temperature ≥ 37.5°C or history of fever in the last 24 hours.

Before becoming pregnant, 9% of women were underweight, and over half (57%) were anaemic (haemoglobin level <11g/L). Pregnancy was confirmed on average at 7.1wg, and women had an average 8.9 scheduled antenatal care (ANC) visits. During pregnancy, 43.1% and 69% of women had at least one episode of malaria infection and anaemia, respectively. Gestational hypertension (2.6%), smoking (<1%), and alcohol consumption (<1%) were infrequent. Multigravidae accounted for 88.8% of the study population. Women were considered overweight or obese in 23.9% of cases. The mean (SD) birthweight was 3031.13 (412.4) grams. There were 3 stillbirths (11.8 per 1000 live births) and 9.0% preterm births (Table 2).

Table 2. Characteristics at birth of the 254 newborns included in the ultrasound study.

RECIPAL cohort, Southern Benin, 2014–2017.

Characteristics Category/Definition Mean (SD) or n (%)
Gender Male 135 (53.1)
Stillbirth Per 1000 live births 3 (11.8 ‰)
Gestational age at birth (weeks) 39.0 (1.7)
Preterm birth * <37 weeks’ GA 22 (8.7%)
Birthweight (g) 3031 (412)
Low birthweight < 2500 g 23 (9.0%)
Birth length (cm) 48.2 (2.6)
Birth head circumference (cm) 34.0 (1.5)

* Preterm birth defined as childbirth before 37 weeks of gestation.

‡ Low birthweight: birthweight < 2500 g, stillbirth and twins excluded.

Comparison of RECIPAL fetal growth pattern to WHO, INTERGROWTH-21st, and Tanzania patterns

The graphic comparison of RECIPAL centiles of HC, AC and FL to those of INTERGROWTH-21st and WHO charts is presented in Figs 2 and S2 and S3. Overall, the centiles for AC in the RECIPAL cohort were closer to WHO than INTERGROWTH-21st as shown in Fig 2 (equations and fitted values for RECIPAL cohort given in S1-S6 Tables in S1 File). For 15–35wg, RECIPAL AC centiles were higher than INTERGROWTH-21st centiles and globally lower than WHO centiles. For EFW, the deviation observed between our study centiles and those of WHO and INTERGROWTH-21st was globally larger than what was observed for AC (Figs 36). For EFW, RECIPAL centiles were closer to WHO centiles (Fig 3) than the two INTERGROWTH-21st centiles using IG21st and Hadlock’s formula suitably (Figs 4 and 5). We confirmed that the use of Hadlock EFW formula with IG21st yielded a much larger difference between RECIPAL and INTERGROWTH-21st centiles (Figs 4 and 5). The comparison between RECIPAL and Tanzanian EFW centiles showed that the 50th and 90th RECIPAL centiles were higher than in the Tanzanian chart (Fig 6). In contrast, the 10th centile was similar for both charts between 25 and 36 wg, after which a decrease was observed for the Tanzanian centiles.

Fig 2. Graphic comparison of RECIPAL study 10th, 50th, and 90th centiles of abdominal circumference (AC) to those of INTERGROWTH-21st and WHO charts.

Fig 2

RECIPAL cohort, Southern Benin, 2014–2017.

Fig 3. Graphic comparison of RECIPAL study 10th, 50th, and 90th centiles of estimated fetal weight (EFW) to that of WHO charts.

Fig 3

Both RECIPAL study and WHO EFWs were calculated using the Hadlock formula. RECIPAL cohort, Southern Benin, 2014–2017.

Fig 6. Graphic comparison of RECIPAL study 10th, 50th, and 90th centiles of estimated fetal weight (EFW) to that of Tanzanian charts.

Fig 6

Both RECIPAL study and Tanzanian charts EFW were calculated using the Hadlock formula. RECIPAL cohort, Southern Benin, 2014–2017.

Fig 4. Graphic comparison of RECIPAL study 10th, 50th, and 90th centiles of estimated fetal weight (EFW) to that of INTERGROWTH-21st charts.

Fig 4

RECIPAL study and INTERGROWTH-21st EFWs were calculated using the INTERGROWTH-21st formula. RECIPAL cohort, Southern Benin, 2014–2017.

Fig 5. Graphic comparison of RECIPAL study 10th, 50th, and 90th centiles of estimated fetal weight (EFW) to that of INTERGROWTH-21st recent charts using Hadlock formula.

Fig 5

RECIPAL study and INTERGROWTH-21st EFWs were calculated using the Hadlock formula as the recent IG21hl. RECIPAL cohort, Southern Benin, 2014–2017.

Comparison of RECIPAL centiles with WHO, INTERGROWTH-21st, and Tanzania centiles using the Bland and Altman percentage difference method

For the biometric measurements, the lowest biases were consistently observed when comparing RECIPAL to WHO centiles than when comparing RECIPAL to INTERGROWTH-21st centiles. Figs 7 and 8 display comparisons of the different charts using the Bland-Altman for the AC and EFW over the GA spectrum and provide the coefficients for the mean differences (S4 and S5 Figs show results for HC and FL). Regardless of the standard considered, the percentage differences were generally greater in early pregnancy with a gradual reduction until the end of the pregnancy. Regarding the 10th centile of EFW, RECIPAL and WHO values were quite similar (percentage difference of -0.23%), INTERGROWTH-21st (IG21st) values were on average 2.24% lower than those of RECIPAL, and -5.0% lower than RECIPAL for the recent IG21hl using Hadlock formula (Fig 8A). Tanzanian values were on average 2.62% lower than those of RECIPAL (Fig 8A). For the 50th and 90th centiles, the observed differences remained of the same magnitude for WHO but were greater for INTERGROWTH-21st and the Tanzanian chart (Fig 8B and 8C).

Fig 7.

Fig 7

Percentage difference in 10th (A), 50th (B), and 90th (C) centiles of abdominal circumference (AC) between RECIPAL centiles and those of WHO and INTERGROWTH-21st. RECIPAL cohort, Southern Benin, 2014–2017.

Fig 8.

Fig 8

Percentage difference in 10th (A), 50th (B), and 90th (C) centiles of estimated fetal weight (EFW) between RECIPAL centiles and those of WHO, INTERGROWTH-21st (IG21st when using INTERGROWTH-21st EFW formula and IG21hl when using the Hadlock formula), and Tanzania. RECIPAL cohort, Southern Benin, 2014–2017.

Prevalence of biometric measurements and EFW <10th percentile according to the standard used

The proportion of fetuses with AC, FL, HC, or EFW <10th centile was higher when using WHO compared to INTERGROWTH-21st standards whenever assessed during pregnancy (Table 3). The new INTERGROWTH-21st centile values for EFW using the Hadlock formula performed similarly as with their own formula. As an internal validation of the modeled centiles using RECIPAL data, the proportion of fetuses with AC, FL, HC, or EFW <10th centile were close to the expected 10% (Table 3 and S7 Table in S1 File).

Table 3. Proportion of fetuses below the 10th percentile according to INTERGROWTH-21st and WHO standards for HC, AC, FL and EFW at 27-32weeks and 33–38 weeks.

Biometric parameter Number (%) of fetuses with values < 10th percentile
RECIPAL TANZANIA IG 21hl IG 21st WHO
n (%) n (%) (based on Hadlock formula for EFW) (based on INTERGROWTH formula for EFW) n (%)
n (%) n (%)
HC (N = 243) 27–32 weeks a 21 (8.6) - - 10 (4.1) 18 (7.4)
HC (N = 232) 33–38 weeks b 23 (9.9) - - 22 (9.5) 22 (9.5)
AC (N = 243) 27–32 weeks a 26 (10.7) - - 15 (6.2) 33 (13.6)
AC (N = 232) 33–38 weeks b 23 (9.9) - - 11 (4.7) 16 (6.9)
FL (N = 243) 27–32 weeks a 27 (11.1) - - 5 (2.1) 10 (4.1)
FL (N = 232) 33–38 weeks b 20 (8.6) - - 6 (2.6) 17 (7.3)
EFW (N = 243) 27–32 weeks a 24 (9.9) 16 (6.6) 13 (5.4) 18 (7.4) 26 (10.7)
EFW (N = 232) 33–38 weeks b 24 (10.3) 20 (8.6) 10 (4.3) 13 (5.6) 27 (11.6)

AC: Abdominal Circumference, HC: Head Circumference, EFW: Estimated Fetal Weight using 1) the Hadlock formula for comparison with WHO fetal growth standard (Kiserud et al., PLoS MED 2017) and with IG21hl standards (Stirnemann et al.; UOG 2020), and 2) the INTERGROWTH21-st formula for comparison with INTERGROWTH-21st fetal growth standard (Papageorghiou et al., Lancet 2014).

a Ultrasound scan performed within 27–32 weeks,

b Ultrasound scan performed within 33–38 weeks. IG21: INTERGROWTH-21st.

Discussion

Using high-quality and prospectively collected ultrasound data early in gestation until delivery in a Beninese population, this study provides novel data assessing the two new international fetal growth standards in an African context. Contrary to expectations, RECIPAL cohort centiles were higher than INTERGROWTH-21st centiles and were close to those of WHO globally despite high rates of malarial infection and anaemia. RECIPAL 10th centile for EFW was similar to that of Tanzania for 25–30wg, after which the difference increased. All these trends were confirmed by the percentage difference analysis and by assessing proportions of fetuses with measures below the 10th percentile.

While high-risk pregnancies were excluded from the WHO, INTERGROWTH-21st, and Tanzanian samples, they were strongly represented in RECIPAL sample with 9% underweight women, between 40% and 70% of women with anaemia or malaria during pregnancy, and an overall proportion of low birth weight of 9% [13, 14]. Therefore, the observed differences between RECIPAL, international, and Tanzanian centiles were smaller than expected. The high proportion of overweight/obese (24%) and multigravid (72%) women may partly explain the high RECIPAL centiles [32, 33]. Also, the optimal follow-up and management of women in our cohort may have contributed to reducing the impact of the various risk factors for FGR. In particular, women were screened for microscopic malaria every month and those infected were treated immediately. This may have mitigated the impact of malarial infection on fetal growth which would be an encouraging result for pregnant women living in high-malaria areas. We could not conduct a sensitivity analysis in women at lower risk of FGR because only 60 women (23%) met the stringent INTERGROWTH-21st and WHO criteria.

We applied both INTERGROWTH-21th and Hadlock formula to estimate fetal weight in our population and our comparison of the two INTERGROWTH-21th standards based on their own and Hadlock formula for EFW provides novel information about these two charts. The INTERGROWTH-21st formula has been found to underestimate fetal weight [18] and this was corroborated in our sample. Both INTERGROWTH-21th standards yielded centiles that were lower than the RECIPAL centiles, with a larger gap for the standards using the Hadlock formula [15, 18, 34].

Limited African data were included in the development of INTERGROWTH-21st (data from Kenya) and WHO (Egypt and Democratic Republic of Congo) charts, although they are recommended for universal use. To our knowledge, only one study has evaluated these new standards in Africa. In Ethiopia, based on 675 singleton pregnancies, local fetal growth patterns (as illustrated by the 50th centile of AC, HC, FL and EFW) were reported to have the same distributions as those from the two international charts [22]. These findings from Ethiopia are difficult to interpret, given the differences between the charts. Furthermore, one might have expected a lower agreement between the two charts since the Hadlock formula was used in both cases to estimate fetal weight. In addition, while their study population included in a high proportion of undernurished women, the 5th local EFW centiles was higher than that of the WHO.

In HICs, studies have led to contradictory results. In Italy, Bellussi et al. concluded that INTERGROWTH-21st and local AC standards were interchangeable for the diagnosis of SGA fetuses [20]. In France, in their study including over 4,800 low-risk pregnancies, Stirnemann et al. concluded that French HC centiles closely matched INTERGROWTH-21st centiles. However, they did not provide a comparison of the centile references for AC and FL, for which the proportions below the 10th centile were far lower than 10% [17]. AC and FL discrepancies between French and INTERGROWTH-21st centiles were also demonstrated using a very large sample of low-risk pregnancies belonging to the French Elfe cohort [35]. Similar results were published by Cheng et al., who showed large differences between the INTERGROWTH-21st standards and the Chinese biometry standards using data collected on more than 10,000 unselected pregnancies. In particular, they found larger proportions of AC, HC, and FL less than 10th using INTERGROWTH-21st compared to their own standards, without a significant increase in the number of very SGA newborns at birth (14). Finally, in accordance with WHO that there may be significant differences between countries, recent studies in HICs also argued in favor of ethnic/geographic-specific fetal growth patterns [15, 21].

The RECIPAL study has several important strengths. In particular, women were recruited and followed up from the preconception period, allowing for accurate dating of the pregnancy by early US. Also, fetal growth was monitored prospectively throughout the pregnancy, making RECIPAL one of the few cohorts in Africa with such high-quality data. However, several limitations must also be considered, the main one being the small size of our study sample. Also, measurements of the fetuses were not equally distributed at each GA throughout the pregnancy, with four peaks at 16, 22, 24, and 28wg, and a low number of USs were performed after 35wg. Therefore, growth patterns starting from 35wg, and particularly the decrease in RECIPAL centiles for AC, must be interpreted with caution. Finally, because of our relatively small sample size, we were unable to develop RECIPAL charts in a selected group of women at low risk. For these reasons, RECIPAL centiles were computed for descriptive and comparative purposes only and not as possible references for Benin.

In conclusion, WHO fetal growth charts seemed to better reflect the Beninese population than INTERGROWTH-21st charts, whatever the standards (IG21st vs. IG21hl) used. However, this finding needs to be confirmed on a larger sample, preferably restricted to low-risk pregnancies. Comparison of these international standards with high-quality African reference charts [11] is also warranted. Such future studies should evaluate to what extent these standards make it possible to identify children at risk of morbidity. In addition to samples of low risk pregnancies, investigations should consider application of these charts in sub-groups at risk, for instance, very low birthweight or preterm births. This is particularly important in African countries where the proportion of SGA newborns is estimated to be as high as 25% and the human and financial resources for the management of these children are limited. Finally, given the limited accuracy of fetal growth standards for identifying fetuses at risk of adverse perinatal outcomes [36], other strategies combining fetal biometry with biomarkers for FGR and women’s clinical characteristics may find their place in the future [37]. Feasibility and cost-effectiveness will be important determinants of the large-scale use of this type of diagnostic tool in Africa.

Supporting information

S1 Fig. Distribution of ultrasound scans throughout pregnancy for fetal growth assessment.

RECIPAL cohort, Southern Benin, 2014–2017.

(TIF)

S2 Fig. Graphic comparison of RECIPAL study 10th, 50th, and 90th centiles of head circumference (HC) to those of INTERGROWTH-21st and WHO charts.

RECIPAL cohort, Southern Benin, 2014–2017.

(TIF)

S3 Fig. Graphic comparison of RECIPAL study 10th, 50th, and 90th centiles of femur length (FL) to those of INTERGROWTH-21st and WHO charts.

RECIPAL cohort, Southern Benin, 2014–2017.

(TIF)

S4 Fig

Percentage difference in 10th (A), 50th (B), and 90th (C) centiles of head circumference (HC) between RECIPAL centiles and those of WHO and INTERGROWTH-21st. RECIPAL cohort, Southern Benin, 2014–2017.

(TIF)

S5 Fig

Percentage difference in 10th (A), 50th (B), and 90th (C) centiles of femur length (FL) between RECIPAL centiles and those of WHO and INTERGROWTH-21st. RECIPAL cohort, Southern Benin, 2014–2017.

(TIF)

S1 File. Supporting tables.

Supplementary Table S1: Equations for the estimation of each percentile using quantile regression of each fetal measurement (in mm) according to gestational age (in weeks). Supplementary Table S2: Centiles of abdominal circumference (N = 241). RECIPAL cohort, Southern Benin, 2014–2017. Supplementary Table S3: Centiles of head circumference (N = 241). RECIPAL cohort, Southern Benin, 2014–2017. Supplementary Table S4: Centiles of estimated fetal weight using the Hadlock formula (N = 241). RECIPAL cohort, Southern Benin, 2014–2017. Supplementary Table S5: Centiles of estimated fetal weight using the INTERGROWTH-21st formula starting from 22 weeks of gestation (N = 241). RECIPAL cohort, Southern Benin, 2014–2017. Supplementary Table S6: Centiles of femur length (N = 241). RECIPAL cohort, Southern Benin, 2014–2017. Supplementary Table S7: The proportion of fetuses with observed values below the threshold of each percentile (Q) using quantile regression to model RECIPAL data, RECIPAL cohort, Southern Benin, 2014–2017.

(DOCX)

Acknowledgments

The authors thank all the local communities of Sô-Ava and Akassato in Benin who took part in this study; all RECIPAL project technical team, the midwives, nurses, community-health workers for the hard work of recruiting and following the study participants.

Abbreviations

FGR

Fetal growth restriction

SGA

Small-for-gestational age

GA

Gestational Age

LMICs

low- and middle-income countries

HIV

Human immunodeficiency virus

HICs

high-income countries

INTERGROWTH-21st

The International Fetal and Newborn Growth Consortium for the 21st Century

WHO

World Health Organization

US

ultrasound scan

RECIPAL

retard de croissance intra-utérin et paludismse

LMP

last menstrual period

wg

weeks of gestation

CRL

crown-rump length

EFW

estimated fetal weight

HC

head circumference

AC

abdominal circumference

FL

femur length

SD

standard deviation

ANC

antenatal care

Data Availability

All relevant data are within the paper and its Supporting Information file.

Funding Statement

This work was supported by the French Agence Nationale de la Recherche (grant number ANR-13-JSV1-0004) and the Fondation Simone Beer under the auspices of the Fondation de France (grant number 00074147), the funding is granted to VB. EY received Idex Travel Scholarship, Excellence Initiative from Bordeaux University in France for MPH studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Kramer MS. The epidemiology of adverse pregnancy outcomes: an overview. J Nutr. 2003;133 5 Suppl 2:1592S–1596S. doi: 10.1093/jn/133.5.1592S [DOI] [PubMed] [Google Scholar]
  • 2.Katz J, Lee AC, Kozuki N, Lawn JE, Cousens S, Blencowe H, et al. Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis. Lancet. 2013;382:417–25. doi: 10.1016/S0140-6736(13)60993-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Lee AC, Kozuki N, Cousens S, Stevens GA, Blencowe H, Silveira MF, et al. Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21st standard: analysis of CHERG datasets. BMJ. 2017;358. doi: 10.1136/bmj.j3677 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Verlijsdonk J-W, Winkens B, Boers K, Scherjon S, Roumen F. Suspected versus non-suspected small-for-gestational age fetuses at term: perinatal outcomes. J Matern Fetal Neonatal Med. 2012;25:938–43. doi: 10.3109/14767058.2011.600793 [DOI] [PubMed] [Google Scholar]
  • 5.Policiano C, Fonseca A, Mendes JM, Clode N, Graça LM. Small-for-gestational-age babies of low-risk term pregnancies: does antenatal detection matter? J Matern Fetal Neonatal Med. 2018;31:1426–30. doi: 10.1080/14767058.2017.1317741 [DOI] [PubMed] [Google Scholar]
  • 6.de Onis M, Habicht JP. Anthropometric reference data for international use: recommendations from a World Health Organization Expert Committee. Am J Clin Nutr. 1996;64:650–8. doi: 10.1093/ajcn/64.4.650 [DOI] [PubMed] [Google Scholar]
  • 7.American College of Obstetricians and Gynecologists. ACOG Practice bulletin no. 134: fetal growth restriction. Obstet Gynecol. 2013;121:1122–33. doi: 10.1097/01.AOG.0000429658.85846.f9 [DOI] [PubMed] [Google Scholar]
  • 8.Accrombessi M, Zeitlin J, Massougbodji A, Cot M, Briand V. What Do We Know about Risk Factors for Fetal Growth Restriction in Africa at the Time of Sustainable Development Goals? A Scoping Review. Paediatr Perinat Epidemiol. 2017. 10.1111/ppe.12433 [DOI] [PubMed] [Google Scholar]
  • 9.Belkacemi L, Nelson DM, Desai M, Ross MG. Maternal undernutrition influences placental-fetal development. Biol Reprod. 2010;83:325–31. doi: 10.1095/biolreprod.110.084517 [DOI] [PubMed] [Google Scholar]
  • 10.Papageorghiou AT, Kennedy SH, Salomon LJ, Altman DG, Ohuma EO, Stones W, et al. The INTERGROWTH-21st fetal growth standards: toward the global integration of pregnancy and pediatric care. Am J Obstet Gynecol. 2018;218:S630–40. doi: 10.1016/j.ajog.2018.01.011 [DOI] [PubMed] [Google Scholar]
  • 11.Schmiegelow C, Scheike T, Oesterholt M, Minja D, Pehrson C, Magistrado P, et al. Development of a fetal weight chart using serial trans-abdominal ultrasound in an East African population: a longitudinal observational study. PLoS ONE. 2012;7:e44773. doi: 10.1371/journal.pone.0044773 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Mikolajczyk RT, Zhang J, Betran AP, Souza JP, Mori R, Gülmezoglu AM, et al. A global reference for fetal-weight and birthweight percentiles. Lancet. 2011;377:1855–61. doi: 10.1016/S0140-6736(11)60364-4 [DOI] [PubMed] [Google Scholar]
  • 13.Kiserud T, Piaggio G, Carroli G, Widmer M, Carvalho J, Neerup Jensen L, et al. The World Health Organization Fetal Growth Charts: A Multinational Longitudinal Study of Ultrasound Biometric Measurements and Estimated Fetal Weight. PLoS Med. 2017;14:e1002220. doi: 10.1371/journal.pmed.1002220 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Papageorghiou AT, Ohuma EO, Altman DG, Todros T, Cheikh Ismail L, Lambert A, et al. International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project. Lancet. 2014;384:869–79. doi: 10.1016/S0140-6736(14)61490-2 [DOI] [PubMed] [Google Scholar]
  • 15.Grantz KL, Hediger ML, Liu D, Buck Louis GM. Fetal growth standards: the NICHD fetal growth study approach in context with INTERGROWTH-21st and the World Health Organization Multicentre Growth Reference Study. Am J Obstet Gynecol. 2018;218:S641-S655.e28. doi: 10.1016/j.ajog.2017.11.593 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Cheng Y, Leung TY, Lao T, Chan YM, Sahota DS. Impact of replacing Chinese ethnicity-specific fetal biometry charts with the INTERGROWTH-21(st) standard. BJOG. 2016;123 Suppl 3:48–55. doi: 10.1111/1471-0528.14008 [DOI] [PubMed] [Google Scholar]
  • 17.Stirnemann JJ, Fries N, Bessis R, Fontanges M, Mangione R, Salomon LJ. Implementing the INTERGROWTH-21st fetal growth standards in France: a “flash study” of the College Français d’Echographie Foetale (CFEF). Ultrasound Obstet Gynecol. 2017;49:487–92. doi: 10.1002/uog.17223 [DOI] [PubMed] [Google Scholar]
  • 18.Monier I, Ego A, Benachi A, Ancel P-Y, Goffinet F, Zeitlin J. Comparison of the Hadlock and INTERGROWTH formulas for calculating estimated fetal weight in a preterm population in France. American Journal of Obstetrics & Gynecology. 2018;219:476.e1-476.e12. [DOI] [PubMed] [Google Scholar]
  • 19.Hua X, Shen M, Reddy UM, Buck Louis G, Souza JP, Gülmezoglu AM, et al. Comparison of the INTERGROWTH-21st, National Institute of Child Health and Human Development, and WHO fetal growth standards. Int J Gynaecol Obstet. 2018;143:156–63. doi: 10.1002/ijgo.12637 [DOI] [PubMed] [Google Scholar]
  • 20.Bellussi F, Cataneo I, Visentin S, Simonazzi G, Lenzi J, Fantini MP, et al. Clinical Validation of the INTERGROWTH-21st Standards of Fetal Abdominal Circumference for the Prediction of Small-for-Gestational-Age Neonates in Italy. Fetal Diagn Ther. 2017;42:198–203. doi: 10.1159/000457121 [DOI] [PubMed] [Google Scholar]
  • 21.Sletner L, Kiserud T, Vangen S, Nakstad B, Jenum AK. Effects of applying universal fetal growth standards in a Scandinavian multi-ethnic population. Acta Obstet Gynecol Scand. 2018;97:168–79. doi: 10.1111/aogs.13269 [DOI] [PubMed] [Google Scholar]
  • 22.Roro M, Deressa W, Lindtjørn B. Intrauterine growth patterns in rural Ethiopia compared with WHO and INTERGROWTH-21st growth standards: A community-based longitudinal study. PLoS ONE. 2019;14:e0226881. doi: 10.1371/journal.pone.0226881 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Accrombessi M, Yovo E, Cottrell G, Agbota G, Gartner A, Martin-Prevel Y, et al. Cohort profile: effect of malaria in early pregnancy on fetal growth in Benin (RECIPAL preconceptional cohort). BMJ Open. 2018;8:e019014. doi: 10.1136/bmjopen-2017-019014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Robinson HP, Fleming JE. A critical evaluation of sonar “crown-rump length” measurements. Br J Obstet Gynaecol. 1975;82:702–10. doi: 10.1111/j.1471-0528.1975.tb00710.x [DOI] [PubMed] [Google Scholar]
  • 25.Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of head, body, and femur measurements—A prospective study. American Journal of Obstetrics and Gynecology. 1985;151:333–7. doi: 10.1016/0002-9378(85)90298-4 [DOI] [PubMed] [Google Scholar]
  • 26.Stirnemann J, Villar J, Salomon LJ, Ohuma E, Ruyan P, Altman DG, et al. International estimated fetal weight standards of the INTERGROWTH-21st Project. Ultrasound in Obstetrics & Gynecology. 2017;49:478–86. doi: 10.1002/uog.17347 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Papageorghiou A, Sarris I, Ioannou C, Todros T, Carvalho M, Pilu G, et al. Ultrasound methodology used to construct the fetal growth standards in the INTERGROWTH-21 st Project. BJOG. 2013;120:27–32. doi: 10.1111/1471-0528.12313 [DOI] [PubMed] [Google Scholar]
  • 28.Sarris I, Ioannou C, Chamberlain P, Ohuma E, Roseman F, Hoch L, et al. Intra- and interobserver variability in fetal ultrasound measurements. Ultrasound in Obstetrics & Gynecology. 2012;39:266–73. doi: 10.1002/uog.10082 [DOI] [PubMed] [Google Scholar]
  • 29.Stirnemann J, Salomon LJ, Papageorghiou AT. INTERGROWTH -21 st standards for Hadlock’s estimation of fetal weight. Ultrasound Obstet Gynecol. 2020;56:946–8. doi: 10.1002/uog.22000 [DOI] [PubMed] [Google Scholar]
  • 30.Giavarina D. Understanding Bland Altman analysis. Biochem Med (Zagreb). 2015;25:141–51. doi: 10.11613/BM.2015.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Altman DG, Bland JM. Measurement in Medicine: The Analysis of Method Comparison Studies. The Statistician. 1983;32:307. [Google Scholar]
  • 32.Shah PS, Knowledge Synthesis Group on Determinants of LBW/PT births. Parity and low birth weight and preterm birth: a systematic review and meta-analyses. Acta Obstet Gynecol Scand. 2010;89:862–75. doi: 10.3109/00016349.2010.486827 [DOI] [PubMed] [Google Scholar]
  • 33.Usta A, Usta CS, Yildiz A, Ozcaglayan R, Dalkiran ES, Savkli A, et al. Frequency of fetal macrosomia and the associated risk factors in pregnancies without gestational diabetes mellitus. Pan Afr Med J. 2017;26. doi: 10.11604/pamj.2017.26.62.11440 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Yue Cheng Yvonne Kwun, Jing Lu, Yeung Leung Tak, Man Chan Yiu, Singh Sahota Daljit. Prospective Assessment of the INTERGROWTH-21 and WHO Estimated Fetal Weight Reference Curve. Ultrasound in Obstetrics & Gynecology. 2017;0 ja. [DOI] [PubMed] [Google Scholar]
  • 35.Heude B, Le Guern M, Forhan A, Scherdel P, Kadawathagedara M, Dufourg M, et al. Are selection criteria for healthy pregnancies responsible for the gap between fetal growth in the French national Elfe birth cohort and the Intergrowth-21st fetal growth standards? Paediatr Perinat Epidemiol. 2019;33:47–56. doi: 10.1111/ppe.12526 [DOI] [PubMed] [Google Scholar]
  • 36.Grangé G. Modalités de dépistage et de diagnostic du fœtus petit pour l’âge gestationnel. Journal de Gynécologie Obstétrique et Biologie de la Reproduction. 2013;42:921–8. [DOI] [PubMed] [Google Scholar]
  • 37.Gaccioli F, Aye ILMH, Sovio U, Charnock-Jones DS, Smith GCS. Screening for fetal growth restriction using fetal biometry combined with maternal biomarkers. American Journal of Obstetrics & Gynecology. 2018;218:S725–37. doi: 10.1016/j.ajog.2017.12.002 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Clive J Petry

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

13 May 2021

PONE-D-21-11431

Assessing fetal growth in Africa: application of the international WHO and INTERGROWTH-21st standards in a Beninese pregnancy cohort

PLOS ONE

Dear Dr. YOVO,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

This manuscript has merit but I agree with the reviewers that revisions need to be made to improve it. Whilst all the points raised by the reviewers need to be either dealt with or robustly rebutted, I think that the most important of these are the first point from reviewer 1 (about the need to transform the data or use non-parametric analysis techniques such as quantile regression) and the point about separating results from healthy pregnancies from those affected by e.g. anaemia/malaria, made by reviewers 2 and 3.

In addition to the points raised by the reviewers, and although the authors state that the data from the study is fully available (one of the publication criteria of this journal), I can not find a file containing the raw data or a link to where I can download it. This does not fit with the journal publication criteria. The data either needs to be included within the revision or a link to a public repository that contains the data needs to be provided.

==============================

Please submit your revised manuscript by Jun 27 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Clive J Petry, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1) Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2) PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

Reviewer #3: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors assessed fetal biometric measurements collected longitudinally in 241 singleton pregnancies and compare the distribution of the data against two existing standards. The study could inform on the selection of the most appropriate standard for their population.

Major:

1)The approach used by the authors to determine the biometrics and EFW centiles 1) assumes data is normally distributed for given gestational age and 2) treats the longitudinal observations from the same subject as independent observations, which are not. Neither IG21, WHO nor other more recent studies (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815382/) rely on such assumptions. Data should be transformed (e.g. Box-Cox transform or log for EFW) to enable normality assumption, or rely on quantile regression instead. Within subject correlations should be dealt with using appropriate techniques (e.g. mixed effects models) or other. At a minimum, these should be stated as limitations and figures based on such models should be moved to the supplement and rely on Table 3 cross-sectional results instead.

2) The analysis in Table 3 should be the main driver or results presented and discussion because they are free of the methodological imitations described in point 1 above. Based on table 3 cross-sectional analyses, EFW values observed herein tend to be higher than the cut-offs derived in the WHO and especially IG21 studies. SGA (<10th) at 33-38 weeks are 8.7% and 4.7% based on WHO and IG21, respectively compared to 10% (expected). Therefore, in this light, and considering comments at point 1, the abstract statement “The difference in both 10 th -centile AC and EFW between WHO and RECIPAL was positive starting from 20wg” is confusing. If EFW 10th centile would be higher in WHO than in this study after 20 weeks, I would expect at 33-38weeks, the rate of SGA <10th should be more than 10% for WHO, but it is only 8.7%. This inconsistency comes from issues outlined in 1.

Reviewer #2: This is an important study made on a optimal set of patients where information could be gathered from pre-conception until delivery.

The serial US is highly informative since it can precise dating - since the earliest US is the most accurate for dating.

Of note that this cohort got optimal care with monitoring monthly malaria infection and treating promptly the patient as soon it is identified. Clearly otherwise outcome would be different.

As such it does not fully represent the high risk population where diagnosis and treatment are limited.

What was important to note that prematurity and stillbirth rates were low- which indicates that adequate management can have significant beneficial effects.

In general access to US is limited especially in time of Covid and also in LMIC therefore a specific time point when US is most accurate to predict IUGR should be better described is it at 28 weeks or after 33 weeks where the margin of error does significantly increase.

For maximizing resources do authors suggest based on their findings how to allocate those resources. For example if urine pregnancy test is instituted and carefully implemented which US if only one time point available should be used.

Overall, it is a well documented study where comparison with other charts of fetal growth are assessed.

Although this population is defined as low risk - it is not. Therefore comparison with chart of healthy patients should be viewed in caution.

Separating the chart between those with malaria/anemia and other without could provide a better insight since it could be compared to low risk population in other charts.

But it is the local reality in that region which also applies to several other African countries so it has to be accepted reality - the best analysis that can be carried out under the circumstances.

The outcome of these pregnancies - since access to newborn care may be limited could also define at what point such US observation when newborn size is <2500 the risk is at high for morbidity. This is clearly different from high resource countries where prematurely born can survive and and develop even when <25 w gestation.

This is especially important if induction is contemplated due to IUGR. Comment on this needed.

Reviewer #3: This study is a potentially important examination of the applicability of 3 standards – 2 international (Intergrowth 21st and WHO) and one from Tanzania, on a maternity cohort in Benin. The local data were from antenatal ultrasound measurements collected in a previous study of a pre-conception cohort of pregnancies (Recipal).

The authors modelled growth from their Recipal database using a polynomial, and compared this with the three standards using percentile differences. The problem with this approach is that their cohort is a reference of the whole population including pathology, whereas the others are standards, based on normal populations excluding pathology. Their method makes it difficult to address the key objective put forward in the title, of how well each of the international standards perform in Benin, by 1. confirming growth in normal pregnancy and 2. identifying pathology associated with fetal growth restriction, such as malaria and anaemia.

The authors state that they did not have sufficient cases to fulfil the stringent criteria for normality used in WHO and IG21 (lines 277-8). However they do not need to equal these criteria to divide their cohort into normal and abnormal outcome pregnancies: this will then allow them to derive antenatal and neonatal SGA rates associated with normal and affected pregnancies according to the 3 standards being investigated, and comment on their suitability for their population. Currently, the method of analysis leaves too many unanswerable questions as to why differences exist.

Altman Bland analyses normally include correlation coefficients with 95% confidence intervals, and this should be included. It would also be interesting to see the systematic and random error for their EFW measurements: if there was a high degree of over-estimation, this could explain low SGA rates. It would also be good to see percent difference within gestational age categories – one would typically expect similar differences across the gestational ages, which was not the case here.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Eytan R Barnea MD FACOG

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Jan 21;17(1):e0262760. doi: 10.1371/journal.pone.0262760.r002

Author response to Decision Letter 0


17 Nov 2021

Response to Reviewer # 1

As suggested by the reviewer we reanalysed the RECIPAL data using quantile regression which does not make any assumption about the normality of the distribution.

As was done by the WHO for developing their standards, correlation between measurements in a single woman was not taken into account. We consulted with the WHO statistical team for their reasoning, which was that mixed-effects models would not affect the estimations of the coefficients, while increasing complexity.

Reassuringly, using this method resulted in only very small changes in the RECIPAL percentile values.

Thank you for these suggestions. We have redone this table and given it more prominence in the manuscript.

Changes also include adding the proportion of fetuses with AC, HC, FL and EFW centiles <10th after RECIPAL modelling, which provides a check of internal validity for the modelling (above).

We also added the recently published INTERGROWTH-21st EFW standards based on the Hadlock formula for estimating fetal weight.

Response to Reviewer # 2

We thank the reviewer for the positive comments about our study.

The reviewer is correct to state that women in the RECIPAL cohort had a better follow-up than Beninese women have in general. These women were tested repeatedly for malaria during their pregnancy and treated. This may be one explanation for our results finding a good correspondence with WHO and fewer fetuses under the 10th percentile than INTERGROWTH-21st . We did not expect this finding since the samples used to construct the charts by WHO and INTERGROWTH-21st were selected to be low-risk. We have added some further discussion of this point on page 16.

Unfortunately, our sample size was not large enough to carry-out meaningful sub-group analysis by risk status, either by defining the sub-population of low-risk women or only women who were malaria-free.

We agree with the reviewer that at the end the standards (whichever they are) must be sensitive and specific enough to identify those foetuses who will be at higher risk of morbidity and mortality. Unfortunately, because of the low number of SGA foetuses we were not able to assess the clinical predictive value of each standard. We have added this as an important area for further research, especially in populations where the outcomes of the highest risk pregnancies could be analysed: on page 19.

Based on the new WHO guidelines, one US before 24 weeks of gestation is recommended. In addition, evolving evidence suggests that combining early US with a “late” third trimester US is beneficial for detecting/confirming third trimester-complications such as FGR and for improving facility-based delivery (Sovio et al., Lancet 2015). The evidence on the impact of US on maternal and perinatal mortality is contrasted to date (Goldenberg et al., BJOG 2018; Saari-Kemppainen et al., Lancet 1990), partly explained by sub-optimal study designs and missed opportunities for adequate clinical management of complications detected by US. Also, one may not exclude that standards used to identify growth-restricted foetuses were not optimal. As mentioned in the manuscript (page 19), “Future studies should evaluate to what extent these standards make it possible to identify children at risk of morbidity.”

Response to Reviewer # 3

In response to the reviewer’s comments, we have clarified the principal purpose of our study, which was to assess the prevalence of FGR during pregnancy using international charts in our cohort. We recognize that our study population does not conform to the low-risk population used for the construction of the WHO and IG prescriptive charts and, indeed, our expectation was that we would find higher proportions of foetuses under the 10th percentile.

This was not the case, which is the paper’s main message. Note that our aim was not to validate these charts against a low-risk population. Malaria, anaemia and maternal underweight are important risk factors for FGR and these are endemic in our population. As explained in our response to reviewer 2, we did not have a sufficient sample size to carry out sub-group analyses which were not planned. For instance, the prevalence of malaria (43%) and anaemia (69%) are high. If we add maternal underweight and clinical malaria, we reduce the sample of women eligible for analysis.

Based on the comments of reviewer 1, we have redone the calculation of the RECIPAL percentiles finding very similar results. We do not believe that there is over-estimation of the ultrasound measures since the study followed a strict protocol with many checks and we have no reason to believe that there would be systematic error in one direction.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Clive J Petry

21 Dec 2021

PONE-D-21-11431R1Assessing fetal growth in Africa: application of the international WHO and INTERGROWTH-21st standards in a Beninese pregnancy cohortPLOS ONE

Dear Dr. YOVO,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================Thank you for submitting the revised version of the manuscript. We have managed to get two of the original reviewers to have another look at it. I agree with their opinions, that the manuscript still requires a little more revision to get it as good as possible. I would therefore like you to complete the revisions suggested by the two reviewers - I won't add anything further to them. I look forward to seeing what should be the final version of the manuscript, which I would enocurage you to submit at your earliest convenience.

==============================

Please submit your revised manuscript by Feb 04 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Clive J Petry, PhD

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Partly

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: The comments were addressed but Table 2 needs to be modified. Confusing.

it is written male,

The text is unclear birth weight = should be newborn weight ....

2500gm ?

Reviewer #3: 1. Authors' revision has addressed main point.

2. Coefficient for Altman Bland plot ought to be added.

3. Inclusion of new version of Intergrowth formula (using Hadlock for EFW) is a good step as it makes results 'current' with formula changes. However note that relevant reference for this correction by IG21 is 29, not 28.

4. Lines 256-7: IG21hl 'did not do better' is wrong term as there are no outcomes to use as a performance standard. Perhaps 'performed similarly' or 'had similar discrepancy to WHO' (as IG21)

5. Lines 331-2 As in 4, as no standard used/available, 'better match' needs to be reworded; perhaps 'seemed to better reflect...'

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Eytan R Barnea MD

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Jan 21;17(1):e0262760. doi: 10.1371/journal.pone.0262760.r004

Author response to Decision Letter 1


2 Jan 2022

Response to Reviewer # 2

We thank the reviewer for the comment regarding the table 2. We have reorganised the table 2 with more details that make it easier to understand

We have referred to birth weight as the weight measured within minutes of the birth of each child.

Response to Reviewer # 3

1. Authors' revision has addressed main point:

We thank the reviewer for the positive comments about the revised version of the paper.

2. Coefficient for Altman Bland plot ought to be added.

Coefficients are shown in Figures 7 and 8, and Supplementary Figures 4 and 5

3. Inclusion of new version of Intergrowth formula (using Hadlock for EFW) is a good step as it makes results 'current' with formula changes. However, note that relevant reference for this correction by IG21 is 29, not 28.

Done,

Thank you very much for your attention which made it possible to correct the numbering error

4. Lines 256-7: IG21hl 'did not do better' is wrong term as there are no outcomes to use as a performance standard. Perhaps 'performed similarly' or 'had similar discrepancy to WHO' (as IG21)

Done,

Thank you for the rewording suggestions which are taken into account

5. Lines 331-2 As in 4, as no standard used/available, 'better match' needs to be reworded; perhaps 'seemed to better reflect...'

Done,

Thank you for the rewording suggestions which are taken into account

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

Clive J Petry

5 Jan 2022

Assessing fetal growth in Africa: application of the international WHO and INTERGROWTH-21st standards in a Beninese pregnancy cohort

PONE-D-21-11431R2

Dear Dr. YOVO,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Clive J Petry, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Clive J Petry

11 Jan 2022

PONE-D-21-11431R2

Assessing fetal growth in Africa: application of the international WHO and INTERGROWTH-21<sup>st<sup> standards in a Beninese pregnancy cohort

Dear Dr. YOVO:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Clive J Petry

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Distribution of ultrasound scans throughout pregnancy for fetal growth assessment.

    RECIPAL cohort, Southern Benin, 2014–2017.

    (TIF)

    S2 Fig. Graphic comparison of RECIPAL study 10th, 50th, and 90th centiles of head circumference (HC) to those of INTERGROWTH-21st and WHO charts.

    RECIPAL cohort, Southern Benin, 2014–2017.

    (TIF)

    S3 Fig. Graphic comparison of RECIPAL study 10th, 50th, and 90th centiles of femur length (FL) to those of INTERGROWTH-21st and WHO charts.

    RECIPAL cohort, Southern Benin, 2014–2017.

    (TIF)

    S4 Fig

    Percentage difference in 10th (A), 50th (B), and 90th (C) centiles of head circumference (HC) between RECIPAL centiles and those of WHO and INTERGROWTH-21st. RECIPAL cohort, Southern Benin, 2014–2017.

    (TIF)

    S5 Fig

    Percentage difference in 10th (A), 50th (B), and 90th (C) centiles of femur length (FL) between RECIPAL centiles and those of WHO and INTERGROWTH-21st. RECIPAL cohort, Southern Benin, 2014–2017.

    (TIF)

    S1 File. Supporting tables.

    Supplementary Table S1: Equations for the estimation of each percentile using quantile regression of each fetal measurement (in mm) according to gestational age (in weeks). Supplementary Table S2: Centiles of abdominal circumference (N = 241). RECIPAL cohort, Southern Benin, 2014–2017. Supplementary Table S3: Centiles of head circumference (N = 241). RECIPAL cohort, Southern Benin, 2014–2017. Supplementary Table S4: Centiles of estimated fetal weight using the Hadlock formula (N = 241). RECIPAL cohort, Southern Benin, 2014–2017. Supplementary Table S5: Centiles of estimated fetal weight using the INTERGROWTH-21st formula starting from 22 weeks of gestation (N = 241). RECIPAL cohort, Southern Benin, 2014–2017. Supplementary Table S6: Centiles of femur length (N = 241). RECIPAL cohort, Southern Benin, 2014–2017. Supplementary Table S7: The proportion of fetuses with observed values below the threshold of each percentile (Q) using quantile regression to model RECIPAL data, RECIPAL cohort, Southern Benin, 2014–2017.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information file.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES